Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingling Xue

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Smart Medicine|January 8, 2025
Microfluidic 3D printing hydrogels based on fish liver decellularized extracellular matrix for liver regenerationHaozhen Ren, Danqing Huang, Mengdi Qiu, et al.
Smart Medicine|May 20, 2025
Polyamine Metabolism Promotes the Progression of Thyroid Carcinoma by Regulating the Immune Phenotype of Tumor Associated MacrophagesHaoran Ding, Lingling Xue, Shaoshi Zhu, et al.
ACS Nano|October 15, 2024
Developing Cell-Membrane-Associated Liposomes for Liver DiseasesDongxue Ge, Ran An, Lingling Xue, et al.
Medcomm|September 23, 2024
Applications of plant-derived extracellular vesicles in medicineYawen Zhu, Junqi Zhao, Haoran Ding, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 25, 2018
Extractability-mediated stability bias and hematocrit impact: High extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysisIris Xie, Yang Xu, Melanie Anderson, et al.
Asia-Pacific Journal of Clinical Oncology|April 20, 2010
Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastasesMark A Rosenthal, Peter Davidson, Frederic Rolland, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Smart Medicine|January 8, 2025
Microfluidic 3D printing hydrogels based on fish liver decellularized extracellular matrix for liver regenerationHaozhen Ren, Danqing Huang, Mengdi Qiu, et al.
Smart Medicine|May 20, 2025
Polyamine Metabolism Promotes the Progression of Thyroid Carcinoma by Regulating the Immune Phenotype of Tumor Associated MacrophagesHaoran Ding, Lingling Xue, Shaoshi Zhu, et al.
ACS Nano|October 15, 2024
Developing Cell-Membrane-Associated Liposomes for Liver DiseasesDongxue Ge, Ran An, Lingling Xue, et al.
Medcomm|September 23, 2024
Applications of plant-derived extracellular vesicles in medicineYawen Zhu, Junqi Zhao, Haoran Ding, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 25, 2018
Extractability-mediated stability bias and hematocrit impact: High extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysisIris Xie, Yang Xu, Melanie Anderson, et al.
Asia-Pacific Journal of Clinical Oncology|April 20, 2010
Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastasesMark A Rosenthal, Peter Davidson, Frederic Rolland, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Pageof 2